Germano Geno J — SEC Form 4 filings
SEC reporting owner CIK 1424383. 15 Form 4 filings on record with FilingPulse; latest filed 2026-08-07.
Transaction summary — filings shown
Covers all 15 filings on record, filed 2024-05-07 to 2026-08-07. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 5 legs across 5 filings — 49,855 shares, $103,371 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 16.
- Largest priced transaction: purchase of 20,000 shares @ $1.49 ($29,800) in Entera Bio Ltd., filed 2026-02-11.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Entera Bio Ltd. (ENTX) | Director | 3 | 2 legs · 40,000 sh · $55,800 | — | 3 |
| PRECISION BIOSCIENCES INC (DTIL) | Director | 8 | 3 legs · 9,855 sh · $47,571 | — | 9 |
| Sage Therapeutics, Inc. (SAGE) | Director | 3 | — | — | 3 |
| Harmony Biosciences Holdings, Inc. (HRMY) | Director | 1 | — | — | 1 |
Form 4 filings — Germano Geno J
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-07 | 4 | Entera Bio Ltd. (ENTX) | Grant/award (A): 25,014 @ $0 · Grant/award (A): 50,000 (derivative) @ $0 · Grant/award (A): 43,014 (derivative) @ $0 | EDGAR |
| 2026-06-05 | 4 | PRECISION BIOSCIENCES INC (DTIL) | Grant/award (A): 20,979 (derivative) @ $0 | EDGAR |
| 2026-05-22 | 4 | PRECISION BIOSCIENCES INC (DTIL) | Option exercise (M): 21,000 · Option exercise (M): 21,000 (derivative) @ $0 | EDGAR |
| 2026-05-18 | 4 | Harmony Biosciences Holdings, Inc. (HRMY) | Grant/award (A): 21,231 (derivative) @ $0 | EDGAR |
| 2026-03-11 | 4 | Entera Bio Ltd. (ENTX) | Purchase (P): 20,000 @ $1.30 | EDGAR |
| 2026-02-11 | 4 | Entera Bio Ltd. (ENTX) | Purchase (P): 20,000 @ $1.49 | EDGAR |
| 2025-12-17 | 4 | PRECISION BIOSCIENCES INC (DTIL) | Purchase (P): 3,000 @ $4.72 | EDGAR |
| 2025-07-31 | 4 | Sage Therapeutics, Inc. (SAGE) | Disposition to issuer (D): 21,500 (derivative) | EDGAR |
| 2025-06-13 | 4 | Sage Therapeutics, Inc. (SAGE) | Grant/award (A): 21,500 (derivative) @ $0 | EDGAR |
| 2025-06-04 | 4 | PRECISION BIOSCIENCES INC (DTIL) | Option exercise (M): 9,826 · Option exercise (M): 9,826 (derivative) @ $0 · Grant/award (A): 21,000 (derivative) @ $0 | EDGAR |
| 2025-03-27 | 4 | PRECISION BIOSCIENCES INC (DTIL) | Purchase (P): 3,250 @ $5.30 | EDGAR |
| 2025-01-02 | 4 | PRECISION BIOSCIENCES INC (DTIL) | Purchase (P): 3,605 @ $4.49 | EDGAR |
| 2024-06-11 | 4 | Sage Therapeutics, Inc. (SAGE) | Grant/award (A): 12,500 (derivative) @ $0 | EDGAR |
| 2024-06-06 | 4 | PRECISION BIOSCIENCES INC (DTIL) | Grant/award (A): 9,826 (derivative) @ $0 | EDGAR |
| 2024-05-07 | 4 | PRECISION BIOSCIENCES INC (DTIL) | Option exercise (M): 4,202 · Option exercise (M): 4,202 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1424383 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →